Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
payday loans online
Popular Articles

Doctor Testifies About Botched Prostate Treatment At VA Hospital
Dr. Gary D. Kao testified Monday about botched prostate cancer treatment he gave to patients at a Veterans Affairs hospital run by the University of Pennsylvania. The New York Times reports: "The radiation oncologist whom regulators accuse of mishandling scores of radioactive seed implants at the Philadelphia veterans" hospital told a Congressional panel on Monday that while he "could have done better" with some implants, his patients over all received effective treatment for their prostrate cancer."
generic viagra online
HHS Secretary Sebelius Announces Senate Confirmation Of Assistant Secretary For Preparedness And Response Dr. Nicole Lurie
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius announced today that the United States Senate unanimously confirmed Dr. Nicole Lurie as the next Assistant Secretary for Preparedness and Response at HHS. Dr. Lurie, an internationally recognized leader in public health, most recently served as co-director of the RAND Corporation Center for Domestic and International Health Security, senior natural scientist and professor of policy analysis at the RAND Corporation.
News of the day
Massachusetts Hospital Sues State Over Cost Of Universal Care
"A hospital that serves thousands of indigent Massachusetts residents sued the state on Wednesday, charging that its costly universal health care law is forcing the hospital to cover too much of the expense of caring for the poor," according to the New York Times.
Diagnostics

FDA Authorizes Emergency Use Of Another Test For 2009 H1N1 Influenza Virus

The U.S. Food and Drug Administration announced it has issued an Emergency Use Authorization (EUA) for a another diagnostic test for the 2009 H1N1 influenza virus, whose spread has caused the virus to be characterized as a pandemic by the World Health Organization. The EUA for the Focus Diagnostics Influenza H1N1 (2009) Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) diagnostic test is the third diagnostic test authorized under an EUA by the FDA since the public health emergency involving the 2009 H1N1 influenza virus was declared on April 26, 2009. The EUA allows Focus Diagnostics to distribute the test to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. This test is not typically utilized in a doctor"s office-it is a complex laboratory test performed in an environment that has the necessary equipment. These tests are intended for use in the detection of the 2009 H1N1 influenza virus in patients with symptoms of respiratory infection. "This authorization will contribute to the nation"s capacity for accurate testing for the 2009 H1N1 influenza virus," said Daniel G. Schultz, M.D., director of the FDA"s Center for Devices and Radiological Health. The Focus Diagnostics test amplifies the viral genetic material obtained from swabs of the nose or throat, or from nasal discharges. A positive result indicates that the patient is infected with the 2009 H1N1 influenza virus. However, the test does not indicate the stage of infection. A negative result does not preclude influenza virus infection. The EUA authority allows the FDA, based on the evaluation of available data and other things, to authorize the use of unapproved medical products or unapproved uses of approved medical products following a determination and declaration of emergency. The Focus Diagnostics test is an unapproved device whose use is authorized by the EUA. The authorization ends when the declaration of emergency is terminated or when the FDA revokes the authorization. Emergency Use Authorization is part of Project BioShield, which became law in July 2004. Focus Diagnostics is based in Cypress, Calif. For more information: FDA"s Guidance on Emergency Use Authorization of Medical Products.. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009